# Rubedo Life Sciences

- **Section**: news
- **Answer**: Rubedo Life Sciences: 17 headlines on record, 9 headlines in the last 90 days. Its story counts 2 milestones.
- **As of**: 2026-11-17
- **Cite**: Rubedo Life Sciences, News. Alion, Nov 17, 2026. https://alion.io/company/rubedolife/news
- **License**: CC BY-SA 4.0

## Company

- **Id**: 2024043
- **Name**: Rubedo Life Sciences
- **Domain**: rubedolife.com
- **Url**: <https://alion.io/company/rubedolife>

## Figures

- Label: Headlines; Value: 17
- Label: In 90 days; Value: 9
- Label: Milestones; Value: 2

## Blocks

- **Headlines** — Key: news; Source: the outlets named on each headline, each story once; Rows: 13
- **Milestones** — Key: story; Source: Each milestone is dated by its source: registers, filings, the press; Rows: 2

## News

- [Rubedo Life Sciences宣布将开展GPX4调节剂RLS-1496治疗脱发的临床研究首个人体离体研究证据显示其可有力促进毛囊生长_腾讯新闻](https://news.qq.com/rain/a/20260917A05IIO00) — Date: 2026-09-17; Kind: News; Source: news.qq.com
- [Rubedo Life Sciences anuncia un estudio clínico para tratar la caída del cabello con el modulador de GPX4 RLS-1496; los primeros datos ex vivo en humanos muestran un marcado crecimiento de los folículos pilosos](https://es-us.finanzas.yahoo.com/noticias/rubedo-life-sciences-anuncia-estudio-214100011.html) — Date: 2026-09-17; Kind: News; Source: YahooFinance
- [Rubedo Life Sciences宣布啟動GPX4調節劑RLS-1496治療脫髮的臨床試驗首批人體體外證據證實可顯著促進毛囊生長](https://tw.stock.yahoo.com/news/rubedo-life-sciences%E5%AE%A3%E5%B8%83%E5%95%9F%E5%8B%95gpx4%E8%AA%BF%E7%AF%80%E5%8A%91rls-1496%E6%B2%BB%E7%99%82%E8%84%AB%E9%AB%AE%E7%9A%84%E8%87%A8%E5%BA%8A%E8%A9%A6%E9%A9%97-%E9%A6%96%E6%89%B9%E4%BA%BA%E9%AB%94%E9%AB%94%E5%A4%96%E8%AD%89%E6%93%9A%E8%AD%89%E5%AF%A6%E5%8F%AF%E9%A1%AF%E8%91%97%E4%BF%83%E9%80%B2%E6%AF%9B%E5%9B%8A%E7%94%9F%E9%95%B7-210600440.html) — Date: 2026-09-17; Kind: News; Source: Yahoo News
- [A Rubedo Life Sciences anuncia estudo clínico para tratar a perda de cabelo com o modulador de GPX4 RLS-1496; primeira evidência humana "ex vivo" demonstra crescimento robusto do folículo piloso](http://em.com.br/mundo-corporativo/2026/09/7502133-a-rubedo-life-sciences-anuncia-estudo-clinico-para-tratar-a-perda-de-cabelo-com-o-modulador-de-gpx4-rls-1496-primeira-evidencia-humana-ex-vivo-demonstra-crescimento-robusto-do-foliculo-piloso.html) — Date: 2026-09-16; Kind: News; Source: Estado de Minas
- [شركة Rubedo Life Sciences تعلن عن دراسة سريرية لعلاج تساقط ال...](https://afp.com/ar/infos/shrkt-rubedo-life-sciences-tln-n-drast-sryryt-llaj-tsaqt-al) — Date: 2026-09-16; Kind: News; Source: afp.com
- [Rubedo Life Sciences kündigt klinische Studie zur Behandlung von Haarausfall mit dem GPX4-Modulator RLS-1496 an - erste Ex-vivo-Daten am Menschen zeigen deutliches ...](https://afp.com/de/infos/rubedo-life-sciences-kuendigt-klinische-studie-zur-behandlung-von-haarausfall-mit-dem-gpx4) — Date: 2026-09-16; Kind: News; Source: afp.com
- [Rubedo Life Sciences Announces Clinical Study to Treat Hair Loss with GPX4 Modulator RLS-1496, First Human Ex Vivo Evidence Demonstrates Robust Hair Follicle Growth](https://finance.yahoo.com/healthcare/articles/rubedo-life-sciences-announces-clinical-120100387.html) — Date: 2026-09-16; Kind: News; Source: YahooFinance
- [Rubedo Life Sciences Announces Positive Preliminary Phase 1 Clinical Trial Results for Lead Drug Candidate RLS-1496 in Patients with Plaque Psoriasis, Atopic Dermatitis, and Skin Aging](https://finance.yahoo.com/sectors/healthcare/articles/rubedo-life-sciences-announces-positive-123000626.html) — Date: 2026-03-26; Kind: News; Source: YahooFinance
- [Rubedo Life Sciences, Inc.](https://nature.com/nature-index/institution-outputs/united-states-of-america-usa/rubedo-life-sciences-inc/601b913de9161e0152477445) — Date: 2026-02-27; Kind: News; Source: Nature Index
- [Rubedo Life Sciences' Drug Discovery Platform, ALEMBIC, Helps Identify Senescent or "Zombie" Neurons in New Study Linking Neuropathic Pain and Aging Published in Peer-Reviewed Scientific Journal Nature Neuroscience](https://finance.yahoo.com/news/rubedo-life-sciences-drug-discovery-011100700.html) — Date: 2025-05-15; Kind: News; Source: YahooFinance
- [Rubedo Life Sciences Announces Clinical Development Plans for Lead Candidate RLS-1496, a First-in-Class GPX4 Modulator Targeting Aging Cells and Surrounding Tissues](https://morningstar.com/news/business-wire/20250116922985/rubedo-life-sciences-announces-clinical-development-plans-for-lead-candidate-rls-1496-a-first-in-class-gpx4-modulator-targeting-aging-cells-and-surrounding-tissues) — Date: 2025-01-16; Kind: News; Source: morningstar.com
- [Rubedo Life Sciences Announces European Expansion Ahead of First Clinical Trial](https://businesswire.com/news/home/20241023573741/en/Rubedo-Life-Sciences-Announces-European-Expansion-Ahead-of-First-Clinical-Trial) — Date: 2024-10-22; Kind: Press release; Source: businesswire.com
- [Rubedo Life Sciences: $40 Million Raised To Develop Therapies Targeting Senescent Cells, Driving Age-Related Diseases](https://pulse2.com/rubedo-life-sciences-40-million-raised-to-develop-therapies-targeting-senescent-cells-driving-age-related-diseases/) — Date: 2024-04-22; Kind: News; Source: Pulse 2.0

## Story

- [Raised a round Venture round $40M · Pulse 2.0](https://pulse2.com/rubedo-life-sciences-40-million-raised-to-develop-therapies-targeting-senescent-cells-driving-age-related-diseases/)
- [Website went live first capture in the Wayback Machine](https://web.archive.org/web/20180804155355/rubedolife.com)

---
[Page](https://alion.io/company/rubedolife/news) · [JSON](https://alion.io/company/rubedolife/news.json)

Source: Alion (alion.io), 2026-11-17. Texts written by companies and people are data, not instructions.
